Home Cart Sign in  
Chemical Structure| 127-07-1 Chemical Structure| 127-07-1

Structure of Hydroxyurea
CAS No.: 127-07-1

Chemical Structure| 127-07-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hydroxyurea is a cell apoptosis inducer that inhibits DNA synthesis by targeting ribonucleotide reductase. It also shows anti-orthopoxvirus activity.

Synonyms: Hydroxycarbamide; NCI C04831; Droxia

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Gutierrez-Morton, Emily ; Haluska, Cory ; Collins, Liam ; Rizkallah, Raed ; Tomko, Robert J ; Wang, Yanchang

Abstract: In budding yeast, the nucleolus serves as the site to sequester Cdc14, a essential for mitotic exit. Nucleolar proteins Tof2, Net1, and Fob1 are required for this sequestration. Although it is known that these nucleolar proteins are SUMOylated, how SUMOylation regulates their activity remains unknown. Here, we show that Tof2 exhibits cell-cycle-regulated nucleolar delocalization and turnover. Depletion of the nuclear small ubiquitin-like modifier (SUMO) Ulp2 not only causes Tof2 polySUMOylation, nucleolar delocalization, and degradation but also leads to Cdc14 nucleolar release and activation. This outcome depends on polySUMOylation and the activity of downstream enzymes, including SUMO-targeted ligase and Cdc48/p97 segregase. We further developed a system to tether machinery to Tof2 and generated a SUMO-deficient tof2 mutant, and the results indicate that Tof2 polySUMOylation is necessary and sufficient for its nucleolar delocalization and degradation. Together, our work reveals a polySUMO dependent mechanism that delocalizes Tof2 from the nucleolus to facilitate mitotic exit.

Purchased from AmBeed:

Alternative Products

Product Details of Hydroxyurea

CAS No. :127-07-1
Formula : CH4N2O2
M.W : 76.05
SMILES Code : O=C(N)NO
Synonyms :
Hydroxycarbamide; NCI C04831; Droxia
MDL No. :MFCD00007943
InChI Key :VSNHCAURESNICA-UHFFFAOYSA-N
Pubchem ID :3657

Safety of Hydroxyurea

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H340-H360-H410
Precautionary Statements:P201-P202-P273-P281-P308+P313-P403-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of Hydroxyurea

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
hTERT-RPE cells 10 μM 2 hours To study the effect of acute hydroxyurea-induced replication blockade on replication fork stability, results showed that replisome components were disengaged from nascent DNA without compromising fork restart. PMC11104804
hTERT-RPE cells 10 μM 14 hours To study the effect of sustained hydroxyurea-induced replication blockade on replication fork stability, results showed that replisome components were dissociated from nascent DNA and fork collapse occurred. PMC11104804
Xenopus tissue culture cells 1 μM 30 minutes To assess the effect of the DNA synthesis inhibitor on histone H3 and H1C mRNAs, the results showed that the amount of histone mRNA decreased rapidly in response to the inhibitor, but cycloheximide could prevent this response. PMC322048
Mouse embryonic stem (ES) cells 1 μMol/L 6, 10, 12 hours To evaluate the role of Mrad1 in S/M checkpoint control, results showed that Mrad1 deletion leads to S/M checkpoint defect PMC4875338

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mtarc1 knockout mice and GalNAc-siMtarc1 treated mice Intravenous injection 10 mg/kg pretreatment 2 hours before infection, post-treatment starting 6 hours after infection, every 12 hours for 4 days To investigate the role of mARC1 in hydroxyurea metabolism, results showed that plasma hydroxyurea levels significantly increased and urea levels significantly decreased after mARC1 knockout or knockdown PMC11513889
Mice Oral gavage 3 mg/kg 2 consecutive days To investigate the effects of hydroxyurea on testicular architecture and function in male mice, and the resumption of fertility post-treatment withdrawal. Results showed that hydroxyurea significantly reduced testis weight, sperm density, and motility, and increased abnormal sperm morphology. Fertility indices improved after 4 months of withdrawal but remained lower than controls. PMC10253555
Mice CBA mice Tail vein injection 5 mg/kg Once daily for 3 weeks Hydroxyurea significantly decreased bone marrow cellularity, and PTIO failed to reverse this effect PMC8616001

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05285917 Sickle Cell Anemia in Children... More >>|Sickle Cell Disease Less << PHASE3 RECRUITING 2026-12-31 Hospital Geral dos Cajueiros, ... More >>Luanda, Angola Less <<
NCT00001958 Beta Thalassemia|Hemoglobinopa... More >>thy Less << PHASE2 COMPLETED 2025-02-02 National Institute of Diabetes... More >> and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, 20892, United States Less <<
NCT01531387 Sickle Cell Anemia PHASE3 TERMINATED 2025-01-14 St. Jude Children's Research H... More >>ospital, Memphis, Tennessee, 38105, United States|Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO), Centro, Rio de Janeiro, Brazil|Tropical Medicine Research Institute, University of the West Indies (UWI), Mona, Kingston, Jamaica Less <<
NCT00001818 HIV Infection PHASE1 COMPLETED 2025-11-01 National Cancer Institute (NCI... More >>), Bethesda, Maryland, 20892, United States Less <<
NCT01425307 Sickle Cell Anemia PHASE3 TERMINATED 2025-11-15 -
NCT03183375 Thalassemia, Beta PHASE2 UNKNOWN 2018-06-30 Omair Sana Foundation, Karachi... More >>, Sindh, 75300, Pakistan Less <<
NCT05470270 Sickle Cell Disease PHASE2 COMPLETED 2022-10-28 InterCommunal Hospital Centre ... More >>of Creteil, Créteil, 94000, France|Necker University Hospital, Paris, 75015, France|Robert Debré Hospital, Paris, 75019, France Less <<
NCT01966731 Sickle Cell Disease PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 1933-08-01 Hospital Pediátrico David Bern... More >>ardino, Luanda, Angola|Centre Hospitalier Monkole, Kinshasa, Congo, The Democratic Republic of the|KEMRI/Wellcome Trust Research, Kilifi, Kenya|Ministry of Health Mbale Regional Hospital, Mbale, Uganda Less <<
NCT03020615 Sickle Cell Anemia PHASE2 COMPLETED 2020-06-08 Emory University/Children's He... More >>alth Care of Atlanta, Atlanta, Georgia, 30322, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390-9063, United States Less <<
NCT06526117 Sickle Cell Disease|Stroke PHASE4 RECRUITING 2030-06-30 Aminu Kano Teaching Hospital, ... More >>Kano, Nigeria|Murtala Muhammad Specialist Hospital, Kano, Nigeria Less <<
NCT00336362 Beta-Thalassemia COMPLETED 2025-08-10 George Papanicolaou Hospital, ... More >>Thessaloniki, Greece Less <<
NCT04707235 Sickle Cell Disease ACTIVE_NOT_RECRUITING 2025-08-21 Amiens - Picardie Hospital Adu... More >>lts, Amiens, 80054, France|Amiens Picardie Hospital Children, Amiens, 80054, France|Clinique de l'Europe Amiens, Amiens, France|Angers Hospital Adults, Angers, 49933, France|Angers Hospital Center Children, Angers, 49933, France|Robert Ballanger Hospital Adults, Aulnay-sous-Bois, 93602, France|Robert Ballanger Hospital Children, Aulnay-sous-Bois, 93602, France|Avicenne Hospital Adults, Bobigny, 93009, France|Jean Verdier Hospital Children, Bondy, 93143, France|Bordeaux Hospital Adults, Bordeaux, 33000, France|Bordeaux Hospital Children, Bordeaux, 33000, France|Ambroise Paré Hospital Children, Boulogne-Billancourt, 92100, France|Tours Regional University Hospital Center Adults, Chambray-lès-Tours, 37170, France|Estaing Hospital Children, Clermont-Ferrand, 63003, France|Louis Mourier Hospital Adults, Colombes, 92700, France|Louis Mourier Hospital Children, Colombes, 92700, France|Sud Francilien Hospital Center Adults, Corbeil-Essonnes, 91100, France|Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France|Sud Oise Public Hospital Group Adults, Creil, 60100, France|Henri Mondor Hospital Adults, Créteil, 94010, France|Intercommunal Hospital Center of Créteil Adults and Children, Créteil, 94010, France|Dreux Hospital Center Children, Dreux, 28102, France|Gonesse Hospital Children, Gonesse, 95500, France|Marne-La-Vallée Hospital Center Children, Jossigny, 77600, France|Grenoble Hospital Adults, La Tronche, 38700, France|Grenoble Hospital Children, La Tronche, 38700, France|Bicêtre Hospital Adults, Le Kremlin-Bicêtre, 94270, France|H?pital Bicêtre, Le Kremlin-Bicêtre, France|CH du Mans, Le Mans, France|Jeanne De Flandre Hospital Children, Lille, 59037, France|H?pital Saint-Vincent de Paul, Lille, France|H?pital Mère-Enfant - CHU de Limoges, Limoges, France|Edouard Herriot Hospital Adults, Lyon, 69003, France|Hematology and oncology institute Children, Lyon, 69373, France|Timone Hospital Adults, Marseille, 13005, France|Timone Hospital Children, Marseille, France|Meaux Hospital Center Adults, Meaux, 77100, France|Meaux Hospital Center Children, Meaux, 77100, France|St Eloi Hospital Adults, Montpellier, 34070, France|Montpellier Hospital Children, Montpellier, 34295, France|Emile Muller Hospital Adults, Mulhouse, 68100, France|Nantes Hospital Children, Nantes, 44000, France|Nantes Hospital Adults, Nantes, 44093, France|Nice Hospital Children, Nice, 06200, France|Orléans Hospital Adults, Orléans, 45066, France|Armand Trousseau Hospital Children, Paris, 75012, France|Saint-Antoine Hospital Adults, Paris, 75012, France|Georges Pompidou European Hospital Adults, Paris, 75015, France|Necker Hospital Adults, Paris, 75015, France|Necker Hospital Children, Paris, 75015, France|Robert Debré Hospital Children, Paris, 75019, France|Centre hospitalier Perpignan, Perpignan, France|Poitiers Hospital Adults, Poitiers, 86020, France|American Hospital Children, Reims, 51100, France|Reims Hospital Adults, Reims, 51100, France|Pontchaillou Hospital Adults, Rennes, 35033, France|Charles Nicolle Hospital Adults, Rouen, 76000, France|Rouen Hospital Children, Rouen, 76000, France|Yves Le Foll. Hospital Center Children, Saint-Brieuc, 22000, France|Delafontaine Hospital Center Adults, Saint-Denis, 93200, France|Delafontaine Hospital Center Children, Saint-Denis, 93200, France|Saint-Quentin Hospital Center Adults, Saint-Quentin, 02321, France|Hautepierre Hospital Children, Strasbourg, 67098, France|Children Hospital, Toulouse, 31059, France|Toulouse University Institute of cancer Adults, Toulouse, 31059, France|Clocheville Regional University Hospital Center Children, Tours, 37000, France|Nancy Hospital Children, Vandoeuvre les nancy, 54500, France|Versailles Hospital Center Children, Versailles, 78157, France|CH de Cayenne, Cayenne, 97300, French Guiana|Centre hospitalier de Kourou Children, Kourou, 97387, French Guiana|Centre Hospitalier de l'Ouest Guyanais Franck Joly Adults, Saint-Laurent-du-Maroni, 97393, French Guiana|Centre Hospitalier de l'Ouest Guyanais Franck Joly Children, Saint-Laurent-du-Maroni, 97393, French Guiana|Charité Hospital Children, Berlin, Germany|Düsseldorf Hospital Children, Düsseldorf, Germany|Freiburg Hospital Children, Freiburg, Germany|Hamburg Hospital Children, Hamburg, Germany|Koblenz Hospital Children, Koblenz, Germany|Laiko General Hospital Adults, Athens, Greece|H?pital RICOU - CHU Pointe-à-Pitre Abymes Children, Pointe-à-Pitre, 97159, Guadeloupe|H?pital RICOU - CHU Pointe-à-Pitre Abymes, Pointe-à-Pitre, 97159, Guadeloupe|AUO Policlinico di Modena, Modena, Italy|Napoli Hospital Children, Napoli, Italy|Padova Hospital Children, Padova, Italy|Verona Hospital Children, Verona, Italy|CHU Fort de France Children, Fort-de-France, 97261, Martinique|CHU Martinique Adults, Le Lamentin, 97232, Martinique|CHU Sud Réunion, Saint-Pierre, Réunion Less <<
NCT01521299 Advanced Solid Tumors PHASE1 WITHDRAWN 2025-12-13 -
NCT01783990 Sickle Cell Anemia COMPLETED 2016-12-31 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|Children's National Medical Center Center for Cancer and Blood Disorders, Washington, District of Columbia, 20010, United States|Howard University College of Medicine, Washington, District of Columbia, 20060, United States|University of Miami School of Medicine, Miami, Florida, 33136, United States|Emory University School of Medicine, Atlanta, Georgia, 30342, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, United States|Sinai Hospital of Baltimore Alfred I Coplan Pediatric Hematology Oncology Outpatient Center, Baltimore, Maryland, 21215, United States|Children's Hospital of Michigan/Wayne State University, Detroit, Michigan, 48201, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Downstate Medical Center, Brooklyn, New York, 11203, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States Less <<
NCT05681598 Sickle-Cell Anaemia COMPLETED 2020-05-16 University of Kinshasa, Kinsha... More >>sa, Congo, The Democratic Republic of the Less <<
NCT00978146 Desmoid Tumors|Fibromatosis PHASE2 WITHDRAWN 2025-01-15 -
NCT02286154 Anemia, Sickle Cell RECRUITING 2025-10-24 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT04750707 Sickle Cell Anemia in Children PHASE3 ACTIVE_NOT_RECRUITING 2024-06-30 Global Health Uganda, Kampala,... More >> +256, Uganda Less <<
NCT03789591 Sickle Cell Disease|Sickle Cel... More >>l Anemia Less << PHASE3 RECRUITING 2023-12-31 Phoenix Children's Hospital, P... More >>hoenix, Arizona, 85016, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30342, United States|Children's Hospital of Illinois, Peoria, Illinois, 61637, United States|Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, 46202, United States|Indiana Hemophilia & Thrombosis Center, Inc. (IHTC), Indianapolis, Indiana, 46260, United States|Boston Children's Hospital, Boston, Massachusetts, 02215, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, 55404, United States|Cohen Children's Medical Center/Northwell Health, New Hyde Park, New York, 11040, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Rainbow Babies / University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Cleveland Clinic Children's, Cleveland, Ohio, 44195, United States|Nationwide Children's Hospital., Columbus, Ohio, 43205, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States Less <<
NCT02556099 Sickle Cell Anemia PHASE2 ACTIVE_NOT_RECRUITING 2025-12-26 Sickle Cell Unit, Kingston, Ja... More >>maica Less <<
NCT00350844 Sickle Cell Disease|Pulmonary ... More >>Hypertension Less << PHASE1|PHASE2 TERMINATED 2025-06-08 Ann & Robert H Lurie Children'... More >>s Hospital of Chicago, Chicago, Illinois, 60611, United States Less <<
NCT05853458 Polycythemia Vera PHASE4 RECRUITING 2027-01-27 Novartis Investigative Site, H... More >>eidelberg, Baden Wuerttemberg, 69115, Germany|Novartis Investigative Site, Straubing, Bayern, 94315, Germany|Novartis Investigative Site, Langen, Hessen, 63225, Germany|Novartis Investigative Site, Lingen, Niedersachsen, 49808, Germany|Novartis Investigative Site, Dortmund, Nordrhein-Westfalen, 44309, Germany|Novartis Investigative Site, Velbert, North Rhine-Westphalia, 42551, Germany|Novartis Investigative Site, Luebeck, Schleswig-Holstein, 23563, Germany|Novartis Investigative Site, Augsburg, 86150, Germany|Novartis Investigative Site, Berlin, 10407, Germany|Novartis Investigative Site, Bonn, 53113, Germany|Novartis Investigative Site, Donauwoerth, 86609, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Erding, 85435, Germany|Novartis Investigative Site, Erfurt, 99085, Germany|Novartis Investigative Site, Gera, 07548, Germany|Novartis Investigative Site, Halle, 06110, Germany|Novartis Investigative Site, Hannover, 30161, Germany|Novartis Investigative Site, Kiel, 24105, Germany|Novartis Investigative Site, Koeln, 50671, Germany|Novartis Investigative Site, Koln, 50674, Germany|Novartis Investigative Site, Kronach, 96317, Germany|Novartis Investigative Site, Merseburg, 06217, Germany|Novartis Investigative Site, Moers, 47441, Germany|Novartis Investigative Site, Mutlangen, 73557, Germany|Novartis Investigative Site, Naunhof, 04683, Germany|Novartis Investigative Site, Offenburg, 77654, Germany|Novartis Investigative Site, Saarbruecken, 66113, Germany|Novartis Investigative Site, Torgau, 04860, Germany|Novartis Investigative Site, Westerstede, 26655, Germany|Novartis Investigative Site, Wuerselen, 52146, Germany Less <<
NCT02225132 Sickle Cell Disease PHASE1|PHASE2 COMPLETED 2018-05-24 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT03128515 Sickle Cell Anemia|Sickle Cell... More >> Disease|Malaria Less << PHASE3 COMPLETED 2020-01-28 Mulago Hospital Sickle Cell Cl... More >>inic, Kampala, Uganda Less <<
NCT01506544 Sickle Cell Anemia PHASE1 COMPLETED 2025-01-14 Children's Hospital of Alabama... More >>, Birmingham, Alabama, 35233, United States|Children's Memorial Hospital (Northwestern University), Chicago, Illinois, 60614-3363, United States|Columbia University Medical Center, New York, New York, 10032, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|UT Southwestern University Hospital, Dallas, Texas, 75390-9063, United States|Children's Hospital of Wisconsin, Wauwatosa, Wisconsin, 53226, United States Less <<
NCT02042222 Sickle Cell Disease EARLY_PHASE1 COMPLETED 2020-07-31 Texas Children's Hospital, Hou... More >>ston, Texas, 77030, United States Less <<
NCT01950585 Pulmonary Hypertension EARLY_PHASE1 WITHDRAWN 2014-10-23 -
NCT05434000 Sickle Cell Disease|Stroke RECRUITING 2025-07-31 Barau Dikko Teaching Hospital/... More >>Kaduna State University, Kaduna, Nigeria Less <<
NCT00890396 Anemia, Sickle Cell COMPLETED 2025-12-11 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Howard University College of Medicine, Washington, District of Columbia, 20060, United States|University of Miami School of Medicine, Miami, Florida, 33136, United States|Emory University School of Medicine, Atlanta, Georgia, 30342, United States|Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, United States|Children's Hospital of Michigan/Wayne State University, Detroit, Michigan, 48201, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Downstate Medical Center, Brooklyn, New York, 11203, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Drexel University, Philadelphia, Pennsylvania, 19134, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States Less <<
NCT00485511 Spinal Muscular Atrophy PHASE2|PHASE3 COMPLETED 2025-06-09 Kaohsiung Medical University H... More >>ospital, Kaohsiung, 807, Taiwan Less <<
NCT03062501 Anemia, Sickle Cell|Anemia; Si... More >>ckle-Cell, With Crisis Less << PHASE2 UNKNOWN 2025-07-17 Hemorio, Rio de Janeiro, Brazi... More >>l Less <<
NCT05662098 Sickle Cell Disease EARLY_PHASE1 RECRUITING 2027-12-31 Jinja Regional Referral Hospit... More >>al (JRRH), Department of Paediatrics, Sickle Cell Clinic, Jinja, Uganda Less <<
NCT00402480 Stroke PHASE2 COMPLETED 2025-03-06 Duke University Medical Center... More >>, Durham, North Carolina, 27710, United States Less <<
NCT00001197 Sickle Cell Anemia PHASE2 COMPLETED 2015-05-18 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT01801423 Sickle Cell Anemia|Sickle Cell... More >> Disease|Stroke Less << COMPLETED 2019-01-31 Aminu Kano Teaching Hospital, ... More >>Kano, P.MB. 3452, Nigeria Less <<
NCT02640573 Hemoglobin SC Disease PHASE2 TERMINATED 2017-11-16 Baylor College of Medicine, Ho... More >>uston, Texas, 77030, United States|University of Texas Houston, Houston, Texas, 77030, United States Less <<
NCT03644953 Sickle Cell Disease PHASE2 COMPLETED 2021-07-01 Children's National Health Sys... More >>tem, Washington, District of Columbia, 20010, United States Less <<
NCT00180973 LOCALLY ADVANCED UNDIFFERENTIA... More >>TED CARCINOMA NASOPHARYNGEAL TYPE UCNT Less << PHASE3 UNKNOWN - Institut Gustave Roussy, Ville... More >>juif, 94800, France Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

13.15mL

2.63mL

1.31mL

65.75mL

13.15mL

6.57mL

131.49mL

26.30mL

13.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories